Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin

NCT00456248 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped slow enrollment

Conditions

Hepatitis C

Interventions

DRUG: Infergen and ribavirin

Sponsor

Kadmon Corporation, LLC